SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-20-081243
Filing Date
2020-07-06
Accepted
2020-07-06 16:31:55
Documents
2
Period of Report
2020-07-01

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 3694
2 EX-24 ex-24.htm EX-24 7454
  Complete submission text file 0001104659-20-081243.txt   12539
Mailing Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312
Business Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312 610-727-3913
Annovis Bio, Inc. (Issuer) CIK: 0001477845 (see all company filings)

IRS No.: 262540421 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 227 7TH AVENUE NE ST. PETERSBURG FL 33701
Business Address
White Mark K. (Reporting) CIK: 0001786183 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39202 | Film No.: 201013849